In hepatocellular cancer cell lines, atorvastatin has been shown to block both the phosphorylation and activation of Myc which is an oncogene related closely to hepatocarcinogenesis, and inhibit tumor initiation and growth 18. The gene discussed is MYC; the disease is neoplasm.